2-Hydroxymyristic acid

Drug Profile

2-Hydroxymyristic acid

Alternative Names: 2-HM; 2-Hydroxytetradecanoic acid

Latest Information Update: 10 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BTG
  • Class Antivirals
  • Mechanism of Action Myristoyl transferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Viral infections

Most Recent Events

  • 29 Jul 1999 2-Hydroxymyristic acid is available for licensing (http://www.btg.co.uk/technologies/anti_infectives.asp)
  • 29 Jul 1999 New profile
  • 29 Jul 1999 Preclinical development for Viral infections in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top